These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 23679279)

  • 1. Seroreactivity to Helicobacter pylori antigens as a risk indicator of gastric cancer.
    Karami N; Talebkhan Y; Saberi S; Esmaeili M; Oghalaie A; Abdirad A; Mostafavi E; Hosseini ME; Mohagheghi MA; Mohammadi M
    Asian Pac J Cancer Prev; 2013; 14(3):1813-7. PubMed ID: 23679279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Seroreactivity to specific antigens of Helicobacter pylori infection is associated with an increased risk of the dyspeptic gastrointestinal diseases.
    Chomvarin C; Ottiwet O; Hahnvajanawong C; Intapan PM; Wongwajana S
    Int J Infect Dis; 2009 Sep; 13(5):647-54. PubMed ID: 19233700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Seroreactivity to 19.5-kDa antigen in combination with absence of seroreactivity to 35-kDa antigen is associated with an increased risk of gastric adenocarcinoma.
    Chua TS; Fock KM; Chan YH; Dhamodaran S; Sim CS; Ng TM; Teo EK
    Helicobacter; 2002 Aug; 7(4):257-64. PubMed ID: 12165034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A CagA-independent cluster of antigens related to the risk of noncardia gastric cancer: associations between Helicobacter pylori antibodies and gastric adenocarcinoma explored by multiplex serology.
    Song H; Michel A; Nyrén O; Ekström AM; Pawlita M; Ye W
    Int J Cancer; 2014 Jun; 134(12):2942-50. PubMed ID: 24259284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serological response to specific Helicobacter pylori antigens: antibody against CagA antigen is not predictive of gastric cancer in a developing country.
    Mitchell HM; Hazell SL; Li YY; Hu PJ
    Am J Gastroenterol; 1996 Sep; 91(9):1785-8. PubMed ID: 8792699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serologic response to lower-molecular-weight proteins of H. pylori is related to clinical outcome of H. pylori infection in Taiwan.
    Shiesh SC; Sheu BS; Yang HB; Tsao HJ; Lin XZ
    Dig Dis Sci; 2000 Apr; 45(4):781-8. PubMed ID: 10759250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low molecular weight protein of Helicobacter pylori and its relation to gastroduodenal diseases.
    Kuo CH; Wu DC; Lu CY; Su YC; Yu FJ; Lee YC; Wu IC; Lin SR; Liu CS; Jan CM; Wang WM
    Hepatogastroenterology; 2003; 50(52):897-901. PubMed ID: 12845945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is the association between Helicobacter pylori and gastric cancer confined to CagA-positive strains?
    Held M; Engstrand L; Hansson LE; Bergström R; Wadström T; Nyrén O
    Helicobacter; 2004 Jun; 9(3):271-7. PubMed ID: 15165264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of Helicobacter pylori CagA+ strains and risk of adenocarcinoma of the stomach and esophagus.
    Wu AH; Crabtree JE; Bernstein L; Hawtin P; Cockburn M; Tseng CC; Forman D
    Int J Cancer; 2003 Mar; 103(6):815-21. PubMed ID: 12516104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibody response to Helicobacter pylori CagA and heat-shock proteins in determining the risk of gastric cancer development.
    Iaquinto G; Todisco A; Giardullo N; D'Onofrio V; Pasquale L; De Luca A; Andriulli A; Perri F; Rega C; De Chiara G; Landi M; Taccone W; Leandro G; Figura N
    Dig Liver Dis; 2000; 32(5):378-83. PubMed ID: 11030181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of cagA in relation to clinical presentation of Helicobacter pylori infection in Egypt.
    Said Essa A; Alaa Eldeen Nouh M; Mohammed Ghaniam N; Graham DY; Said Sabry H
    Scand J Infect Dis; 2008; 40(9):730-3. PubMed ID: 19086246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum antibodies against Helicobacter pylori proteins VacA and CagA are associated with increased risk for gastric adenocarcinoma.
    Rudi J; Kolb C; Maiwald M; Zuna I; von Herbay A; Galle PR; Stremmel W
    Dig Dis Sci; 1997 Aug; 42(8):1652-9. PubMed ID: 9286230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of Helicobacter pylori infection and intestinal metaplasia in subjects who had undergone surgery for gastric adenocarcinoma in Northwest Italy.
    Palestro G; Pellicano R; Fronda GR; Valente G; De Giuli M; Soldati T; Pugliese A; Taraglio S; Garino M; Campra D; Cutufia MA; Margaria E; Spinzi G; Ferrara A; Marenco G; Rizzetto M; Ponzetto A
    World J Gastroenterol; 2005 Dec; 11(45):7131-5. PubMed ID: 16437659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Helicobacter pylori infection combined with CagA and pepsinogen status on gastric cancer development among Japanese men and women: a nested case-control study.
    Sasazuki S; Inoue M; Iwasaki M; Otani T; Yamamoto S; Ikeda S; Hanaoka T; Tsugane S;
    Cancer Epidemiol Biomarkers Prev; 2006 Jul; 15(7):1341-7. PubMed ID: 16835334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Response of IgG1 and IgG2 subclasses to Helicobacter pylori in subjects with chronic inflammation of the gastric mucosa, atrophy and gastric cancer in a country with high Helicobacter pylori infection prevalence.
    Vorobjova T; Ren Z; Dunkley M; Clancy R; Maaroos HI; Labotkin R; Kull K; Uibo R
    APMIS; 2006 May; 114(5):372-80. PubMed ID: 16725014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk for gastric cancer in people with CagA positive or CagA negative Helicobacter pylori infection.
    Parsonnet J; Friedman GD; Orentreich N; Vogelman H
    Gut; 1997 Mar; 40(3):297-301. PubMed ID: 9135515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of gastric cancer among smokers infected with Helicobacter pylori.
    Brenner H; Arndt V; Bode G; Stegmaier C; Ziegler H; Stümer T
    Int J Cancer; 2002 Mar; 98(3):446-9. PubMed ID: 11920598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibody against Helicobacter pylori CagA and VacA and the risk for gastric cancer.
    Yamaoka Y; Kodama T; Kashima K; Graham DY
    J Clin Pathol; 1999 Mar; 52(3):215-8. PubMed ID: 10450182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of Helicobacter pylori vacA, cagA, cagE, iceA, babA2 genotypes and correlation with clinical outcome in Turkish patients with dyspepsia.
    Erzin Y; Koksal V; Altun S; Dobrucali A; Aslan M; Erdamar S; Dirican A; Kocazeybek B
    Helicobacter; 2006 Dec; 11(6):574-80. PubMed ID: 17083380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Helicobacter pylori infection and gastric atrophy: risk of adenocarcinoma and squamous-cell carcinoma of the esophagus and adenocarcinoma of the gastric cardia.
    Ye W; Held M; Lagergren J; Engstrand L; Blot WJ; McLaughlin JK; Nyrén O
    J Natl Cancer Inst; 2004 Mar; 96(5):388-96. PubMed ID: 14996860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.